Eling Pharmaceutical announced that Wanyang Hengshui Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, has received a European Pharmacopeia certificate of applicability for anastrozole APIs issued by the European Medicines Quality Administration. Anastrozole is a nonsteroidal aromatase inhibitor, mainly used to treat estrogen-related tumors. This certification indicates that the product has the qualifications to enter the EU and other markets that recognize CEP certificates in the form of APIs, which has a positive impact on the company's expansion into the international market.

Eling Pharmaceutical announced that Wanyang Hengshui Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, has received a European Pharmacopeia certificate of applicability for anastrozole APIs issued by the European Medicines Quality Administration. Anastrozole is a nonsteroidal aromatase inhibitor, mainly used to treat estrogen-related tumors. This certification indicates that the product has the qualifications to enter the EU and other markets that recognize CEP certificates in the form of APIs, which has a positive impact on the company's expansion into the international market.